lp-a
.org
Login
Library
Trials
Agents
Guidelines
Education
Video
Timeline
Topics
FAQ
About
Home
›
Topics
›
Antisense
Antisense
1 items
Trials, agents, guidance
Agent
Pelacarsen (TQJ230, AKCEA-APO(a)-LRx)
Phase 3 complete; Lp(a)HORIZON outcomes trial neutral (AHA 2026, NEJM 7 November 2026); replaced apheresis in Lp(a)FRONTIERS APHERESIS (2026)